Christopher W. Kersey serves as the Founding Managing Partner of Havencrest Capital Management, and prior to founding Havencrest, Dr. Kersey served as a Managing Member and Partner of Camden Partners Holdings, LLC.

Dr. Kersey currently serves on the board of trustees of the Johns Hopkins Hospital Endowment Fund and the board of directors of Johns Hopkins Medicine International, and he was a founding board member of Johns Hopkins Aramco Healthcare (JHAH) — a joint venture based in Saudi Arabia and one of the world’s largest population health management initiatives.

The former Chairman of the Board of Johns Hopkins Medicine International, Dr. Kersey helped spearhead Johns Hopkins Medicine International’s growth from 2011 – 2017 from an emerging pioneer to the established leader in global collaborative health care partnerships by engineering innovative private sector – public sector partnerships with blue-chip institutions such as Saudi Aramco in the Kingdom of Saudi Arabia, HCL Healthcare in India and Pacifico Salud in Peru.

In 2010, Dr. Kersey was elected to the board of trustees of Johns Hopkins Medicine, a $10 billion integrated global health enterprise and one of the leading academic health care systems in the world, where he now serves as an Emeritus Trustee.

In 2010, Dr. Kersey was also elected to the board of trustees of the iconic Johns Hopkins Hospital, which was ranked as U.S. News & World Report’s #1 ranked hospital in the United States for 21 consecutive years and has been consistently ranked among the best in the country throughout the survey’s 30+ year history, where he now serves as an Emeritus Trustee.

In 2017, Dr. Kersey was elected to the board of trustees of the GuideStone Funds, the largest Christian mutual fund in the world with more than $20 billion in assets under management, where he served on the Investment Management Committee and the Nominating and Governance Committee.

Dr. Kersey earned his Bachelor of Arts (B.A.) degree from Stanford University, his Doctor of Medicine (M.D.) degree from the Emory University School of Medicine and his Master of Business Administration (M.B.A.) from Harvard Business School.